Status:
UNKNOWN
Additional Measles Vaccine at 4 Months of Age
Lead Sponsor:
Bandim Health Project
Conditions:
Measles Infection
Eligibility:
All Genders
4-7 years
Phase:
PHASE4
Brief Summary
Overall objective: To conduct a randomised controlled trial (RCT) to examine whether an early two-dose measles vaccination (MV) strategy at 4 and 9 months will reduce child mortality compared with the...
Eligibility Criteria
Inclusion
- Children aged 4 to 7 months who received the third dose of pentavalent vaccine at least 4 weeks earlier
Exclusion
- Malformations
- Severely ill
- Severely malnourished
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01486355
Start Date
August 1 2011
Last Update
November 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Bissau Region, Guinea-Bissau, 1004